A DNAzyme-CRISPR cascade strategy for preamplification-free detection of Mycobacterium tuberculosis
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Ying Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, DNA, Catalytic, Biosensing Techniques, CRISPR-Cas Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Chongqing Municipal Science and Technology Bureau, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Tuberculosis (TB) remains one of the most fatal infectious diseases worldwide, successful treatment is often limited by insufficient diagnostic capabilities. It creates a pressing need for diagnostic methods that combine high sensitivity, specificity, and operational robustness. In this work, we developed a DNAzyme-CRISPR cascade strategy (Dz-CRISPR) for the specific identification of the IS6110 sequence of Mycobacterium tuberculosis (MTB). This system integrated a thermodynamically stabilized hairpin probe, an Arch-shaped signal transduction switch, and an allosterically activated CRISPR-Cas12a cascade. The design enabled direct target recognition and subsequent signal amplification without a preamplification step, offering a simplified workflow with enhanced stability. The assay demonstrated a detection limit of 211.3 fM and exhibited high specificity by accurately discriminating the IS6110 from specific DNA sequence of non-tuberculous mycobacteria and other common respiratory pathogens. Validation using clinical bronchoalveolar lavage fluid samples further confirmed the method's reliable performance, reproducibility, and satisfactory recovery rates. Current Dz-CRISPR detection strategy provides a reliable and practical solution for tuberculosis diagnosis with high sensitivity, high specificity, and operational robustness, thus demonstrating potential for practical use in resource-constrained areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China; Department of Clinical Laboratory, Chongqing University Jiangjin Hospital, School of Medicine,…
- Key Laboratory of Medical Diagnostics of Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address: huichen@cqmu.edu.cn.
Förderung
- Chongqing Municipal Science and Technology Bureau
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Yu, Y., Zhang, J., Xie, G., Lin, Y., Huang, Y., Rao, C., Hou, Y., & Chen, H. (2026). A DNAzyme-CRISPR cascade strategy for preamplification-free detection of Mycobacterium tuberculosis. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118428
Vancouver
Yu Y, Zhang J, Xie G, Lin Y, Huang Y, Rao C, et al. A DNAzyme-CRISPR cascade strategy for preamplification-free detection of Mycobacterium tuberculosis. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118428
BibTeX
@article{Yu2026,
author = {Yu, Ying and Zhang, Jianhong and Xie, Guoming and Lin, Yu and Huang, Yue and Rao, Chenxin and Hou, Yulei and Chen, Hui},
title = {A DNAzyme-CRISPR cascade strategy for preamplification-free detection of Mycobacterium tuberculosis},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118428}
}
EUVIMED